Therapy News and Research

RSS

Mylan announces launch of Capecitabine Tablets USP, 150 mg and 500 mg

Mylan Inc. today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers.

11 Aug 2014

Patient with mechanical heart pump receives new gene therapy for heart failure

For the first time in the world, a patient with a mechanical heart pump has received a new gene therapy for heart failure at Harefield Hospital, London.

11 Aug 2014

Isoform: New protein offers novel therapeutic approach for patients with DMD

Scientists have discovered a new form of dystrophin, a protein critical to normal muscle function, and identified the genetic mechanism responsible for its production.

11 Aug 2014

Study reveals stem cell therapy as a new potential avenue of treatment for stroke

A stroke therapy using stem cells extracted from patients' bone marrow has shown promising results in the first trial of its kind in humans.

9 Aug 2014

Alexza Pharmaceuticals announces availability of ADASUVE inhalation powder in Guatemala

Alexza Pharmaceuticals, Inc. today announced that ADASUVE inhalation powder, pre-dispensed (loxapine) is now available in Guatemala. This approval represents the first ADASUVE approval in Latin America for Ferrer and Alexza.

8 Aug 2014

BioSpecifics Technologies initiates CCH Phase 2 clinical trial in patients with lipoma

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX in the EU, announced today that it has injected the first patient in its placebo-controlled Phase 2 clinical trial of CCH for the treatment of lipoma.

8 Aug 2014

Scientists analyze genetic characteristics of cancers using multiple genomic technology platforms

New research partly led by UC San Francisco-affiliated scientists suggests that one in 10 cancer patients would be more accurately diagnosed if their tumors were defined by cellular and molecular criteria rather than by the tissues in which they originated, and that this information, in turn, could lead to more appropriate treatments.

8 Aug 2014

Neurons derived from human iPSC and grafted into rats after spinal cord injury produce cells

Building upon previous research, scientists at the University of California, San Diego School of Medicine and Veteran's Affairs San Diego Healthcare System report that neurons derived from human induced pluripotent stem cells (iPSC) and grafted into rats after a spinal cord injury produced cells with tens of thousands of axons extending virtually the entire length of the animals' central nervous system.

8 Aug 2014

Patients treated with drug for type 2 diabetes can live longer than people without the condition

Patients treated with a drug widely prescribed for type 2 diabetes can live longer than people without the condition, a large-scale study involving over 180,000 people has shown.

8 Aug 2014

Patients recovering from total joint replacement surgery who receive AAT require less pain drugs

Patients recovering from total joint replacement surgery who receive animal-assisted therapy (AAT) require less pain medication than those who do not experience this type of therapy.

8 Aug 2014

Longer looks: Kentucky is health law poster child; how to negotiate a lower medical bill; the Ebola outbreak up close

About a year ago, on Aug. 22, a team of inspectors from the Centers for Medicare and Medicaid Services (CMS) unit of the U.S. Department of Health and Human Services arrived in Frankfort, Ky., to see if the people working out of a nondescript warehouse there were going to be able to pull off the launch of Kentucky's Obamacare health-insurance exchange.

8 Aug 2014

Dimethyl fumarate offers no added benefits for adults with RRMS

Dimethyl fumarate has been approved since January 2014 for adults with relapsing remitting multiple sclerosis.

8 Aug 2014

Tumor genetic analysis reveals new approach of classifying cancers

Researchers with The Cancer Genome Atlas (TCGA) Research Network have completed the largest, most diverse tumor genetic analysis ever conducted, revealing a new approach to classifying cancers.

8 Aug 2014

Web-based psychological self-help may aid bipolar patients

A web-based self-management programme appears to be feasible and may be effective as an intervention for people with bipolar disorder.

7 Aug 2014

Physically fit sixth-graders less likely to feel depressed when they reach seventh grade

Physically fit sixth-graders - especially girls - are less likely to report feeling depressed when they reach seventh grade, according to a study presented at the American Psychological Association's 122nd Annual Convention.

7 Aug 2014

New Cardio-Oncology Program to keep hearts beating strong throughout breast cancer treatments

Hearts are at risk when fighting against breast cancer - due to toxic side effects of common treatments like chemotherapy and radiation therapy.

7 Aug 2014

Researchers plan to develop vaccine into a type of antibody serum therapy

By many estimates, an Ebola vaccine could be available in humans as early as next year. But will it be the right one? There are a number of vaccines in development and each is in a race to prove that it is most effective, safe and that it will protect the largest number of people.

7 Aug 2014

EnteroMedics reports net loss of $7.5 million for Q2 2014

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced financial results for the three and six months ended June 30, 2014.

7 Aug 2014

Study sheds light on genetic alterations that may contribute to luminal B breast cancer

Researchers from the Lester and Sue Smith Breast Center at Baylor College of Medicine have uncovered new information about the genetic alterations that may contribute to the development of a subtype breast cancer typically associated with more aggressive forms of the disease and higher recurrence rates.

7 Aug 2014

First Edition: August 7, 2014

Today's headlines include stories about how uninsured people fare with the health law's exemptions.

7 Aug 2014

Therapy News and Research

Mylan announces launch of Capecitabine Tablets USP, 150 mg and 500 mg

Patient with mechanical heart pump receives new gene therapy for heart failure

Isoform: New protein offers novel therapeutic approach for patients with DMD

Study reveals stem cell therapy as a new potential avenue of treatment for stroke

Alexza Pharmaceuticals announces availability of ADASUVE inhalation powder in Guatemala

BioSpecifics Technologies initiates CCH Phase 2 clinical trial in patients with lipoma

Scientists analyze genetic characteristics of cancers using multiple genomic technology platforms

Neurons derived from human iPSC and grafted into rats after spinal cord injury produce cells

Patients treated with drug for type 2 diabetes can live longer than people without the condition

Patients recovering from total joint replacement surgery who receive AAT require less pain drugs

Longer looks: Kentucky is health law poster child; how to negotiate a lower medical bill; the Ebola outbreak up close

Dimethyl fumarate offers no added benefits for adults with RRMS

Tumor genetic analysis reveals new approach of classifying cancers

Web-based psychological self-help may aid bipolar patients

Physically fit sixth-graders less likely to feel depressed when they reach seventh grade

New Cardio-Oncology Program to keep hearts beating strong throughout breast cancer treatments

Researchers plan to develop vaccine into a type of antibody serum therapy

EnteroMedics reports net loss of $7.5 million for Q2 2014

Study sheds light on genetic alterations that may contribute to luminal B breast cancer

First Edition: August 7, 2014

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News